☆ 4.6 Article

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Surgery

Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study

Takuro Matsumoto et al.

Summary: This study aimed to evaluate the prognostic value of systemic inflammation score (SIS) in patients with pT2-4 resectable gastric cancer (GC). The results showed that higher SIS score was associated with undifferentiated cancer and recurrence. SIS was also found to be an independent prognostic factor for relapse-free survival (RFS) and overall survival (OS) in these patients.

BMC SURGERY (2023)

添加到收藏夹

Article Oncology

Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non-muscle-invasive bladder cancer

Kun Ye et al.

Summary: This study aimed to evaluate the potential of the Systemic Inflammatory Response Index (SIRI) as a prognostic factor in non-muscle-invasive bladder cancer (NMIBC) patients treated with intravesical Bacillus Calmette-Guerin (BCG) immunotherapy. The results showed that high SIRI was significantly correlated with non-response to BCG therapy and shorter recurrence-free survival and progression-free survival. The combination of SIRI and T stage demonstrated robust performance in predicting the response to BCG immunotherapy in NMIBC patients.

CANCER MEDICINE (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy

Kabsoo Shin et al.

Summary: The study investigated the prognostic significance of soluble PD-L1 (sPD-L1) and exosomal PD-L1 (exoPD-L1) in patients with gastric cancer receiving chemotherapy. It was found that low levels of sPD-L1 and exoPD-L1 were associated with better overall survival and progression-free survival. Pretreatment sPD-L1 could be used as an independent prognostic factor for overall survival, while exoPD-L1 may reflect the immunosuppressive state of patients.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

Article Oncology

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed et al.

Summary: The study found that blood inflammatory markers can predict the survival and response of patients with advanced hepatocellular carcinoma treated with immunotherapy. Neutrophile to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were identified as independent prognostic factors.

CANCERS (2022)

添加到收藏夹

Article Oncology

Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial

U. T. Hacker et al.

Summary: In this study, the researchers investigated the role of the modified Glasgow prognostic score (mGPS) in predicting sarcopenia and body composition parameters and its prognostic role in conjunction with these parameters. They found that mGPS was strongly prognostic for overall survival (OS) but did not predict a decline in muscle or adipose tissue parameters. Eastern Cooperative Oncology Group performance status with CRP or mGPS remained the only baseline prognostic factors for OS.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

PD-L1 expression and overall survival in Asian and western patients with gastric cancer

Sun Young Rha et al.

Summary: This retrospective study found that PD-L1 expression is not associated with overall survival in gastric cancer patients, and the prevalence of PD-L1 and its association with survival are similar between Korean and US patients.

FUTURE ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases

Agata Buonacera et al.

Summary: Evaluation of the neutrophil-to-lymphocyte ratio (NLR) as a marker of diseases has become a compelling field of research in the past decade. Although an exact cut-off value has not been determined, NLR is recognized as a marker of immune system homeostasis and is correlated with mortality in general population and specific disease subsets. Additionally, NLR has been considered in decision-making processes for COVID-19 pneumonia patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Kohei Shitara et al.

Summary: In patients with gastro-oesophageal adenocarcinoma, nivolumab plus chemotherapy has shown superior overall survival compared to chemotherapy alone.

NATURE (2022)

添加到收藏夹

Article Oncology

Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population

Agnieszka Pikula et al.

Summary: The study confirmed the prognostic value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in advanced gastric cancer patients, serving as significant prognostic factors.

CANCERS (2022)

添加到收藏夹

Review Oncology

Comparison of Treatment Efficacy and Survival Outcomes Between Asian and Western Patients With Unresectable Gastric or Gastro-Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

Zhening Zhang et al.

Summary: The study found that Asian and Western patients with unresectable gastric or gastro-esophageal adenocarcinoma show similar responses to systemic therapies, with potential better survival rates among Asian patients in first-line immunotherapy.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Systematic Review of Prognostic Role of Blood Cell Ratios in Patients with Gastric Cancer Undergoing Surgery

Sabine Schiefer et al.

Summary: This systematic review investigates the prognostic role of blood cell ratios in gastric cancer patients. The study finds that various blood cell ratios are associated with overall survival and disease-free survival. However, the use of different cut-off values hampers the consistency of the findings.

DIAGNOSTICS (2022)

添加到收藏夹

Article Oncology

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

M. Stares et al.

Summary: This study evaluated the prognostic significance of biomarkers of the systemic inflammatory response in patients with advanced non-small-cell lung cancer (NSCLC) receiving first-line pembrolizumab. The results showed that albumin and neutrophil count were independently associated with progression-free survival (PFS) and overall survival (OS). A simple score combining these biomarkers, called Scottish Inflammatory Prognostic Score (SIPS), was developed and found to predict survival in NSCLC patients. SIPS can stratify survival and assist clinicians and patients with treatment decisions.

ESMO OPEN (2022)

添加到收藏夹

Meeting Abstract Oncology

Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648

I. Chau et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

R. Obermannova et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Meeting Abstract Oncology

Local inflammatory biomarkers and their association with systemic inflammation as well as overall survival in primary metastatic gastroesophageal cancer patients

H. Puhr et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

F. Lordick et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

Merel J. M. van Velzen et al.

Summary: This study analyzed the prognostic value of baseline and on-treatment circulating tumor DNA (ctDNA) in metastatic gastroesophageal cancer (mGEC). The results showed that the number of ctDNA mutations before the start of chemotherapy had prognostic value, and the presence of residual ctDNA after treatment was associated with inferior survival.

GASTRIC CANCER (2022)

添加到收藏夹

Article Medicine, General & Internal

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie et al.

Summary: This study found that using ctDNA results to guide treatment decisions for stage II colon cancer reduced the use of adjuvant chemotherapy without compromising recurrence-free survival.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Oncology

Systemic inflammation response index (SIRI) as predictor of anastomotic leakage after total gastrectomy for gastric cancer

Mario Schietroma et al.

Summary: This study suggests that preoperative SIRI may help identify patients at greater risk for developing EJL after total gastrectomy, and it can serve as an independent prognostic factor. Early detection and treatment of EJL may improve patient outcomes.

SURGICAL ONCOLOGY-OXFORD (2022)

添加到收藏夹

Article Medicine, General & Internal

Prognostic Value of Preoperative Systemic Inflammatory Parameters in Advanced Gastric Cancer

Sung Gon Kim et al.

Summary: This study evaluated the association between preoperative systemic inflammatory parameters and overall survival in patients with advanced gastric cancer. The results showed that the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were independent prognostic factors for overall survival in patients with advanced gastric cancer. Additionally, an elevated lymphocyte count was the only factor associated with a favorable prognosis.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Oncology

Inflammatory Ratios as Predictors for Tumor Invasiveness, Metastasis, Resectability and Early Postoperative Evolution in Gastric Cancer

Vlad I. I. Nechita et al.

Summary: Our study evaluated the relationship between inflammatory biomarkers and invasion, metastasis, and resectability in patients with gastric cancer, as well as their predictive value for death during hospitalization or surgical complications. The results showed that higher NLRs, PLRs, and SIIs, as well as lower LMRs, were associated with more aggressive tumors and increased risk of post-operative complications and death during hospitalization.

CURRENT ONCOLOGY (2022)

添加到收藏夹

Article Surgery

High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma

Gerd Jomrich et al.

Summary: The study aimed to determine the clinical role of the systemic immune-inflammation index in patients with resectable adenocarcinoma of the gastroesophageal junction treated with or without neoadjuvant therapy. The findings showed that elevated SII is an independent adverse prognostic factor in patients with resectable gastroesophageal adenocarcinomas with and without neoadjuvant treatment.

ANNALS OF SURGERY (2021)

添加到收藏夹

Article Oncology

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases

Angelika M. Starzer et al.

Summary: The study found that systemic inflammation measured by blood indices NLR, LLR, PLR, MLR, and CRP/Alb was associated with overall survival in patients with brain metastases, and these indices remained independent factors associated with survival in multivariate analysis at the time of diagnosis.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Meeting Abstract Oncology

First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649.

Markus H. Moehler et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Meeting Abstract Oncology

First-line pembrolizumab plus chemotherapy versus chemotherapy in patients with advanced esophageal cancer: Chinese subgroup analysis of KEYNOTE-590.

Zhigang Li et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives

Emilie Moati et al.

Summary: Managing gastrointestinal (GI) cancers is a global challenge, with the need for new tools. Circulating tumor DNA (ctDNA) is a promising non-invasive biomarker that can help clinicians in various aspects of cancer management in the digestive oncology field. ctDNA shows potential in predicting treatment response, monitoring disease progression, and guiding personalized therapy in different GI cancers.

CANCERS (2021)

添加到收藏夹

Article Medical Laboratory Technology

Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer

Yi-Ru Chen et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Review Gastroenterology & Hepatology

Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma

Purabi Dhakras et al.

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Article Oncology

Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas

Madiha Iabal et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients

Ryoichi Miyamoto et al.

EJSO (2018)

添加到收藏夹

Article Oncology

Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy

Angelica Petrillo et al.

FUTURE ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer

Katsutoshi Shoda et al.

GASTRIC CANCER (2017)

添加到收藏夹

Meeting Abstract Oncology

Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer

Y. Choi et al.

ANNALS OF ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer

Tsutomu Namikawa et al.

ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer

Lian Lian et al.

CANCER BIOMARKERS (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer

Kotaro Hirashima et al.

JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Oncology

Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System

Barry J. Laird et al.

CLINICAL CANCER RESEARCH (2013)

添加到收藏夹

Article Oncology

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer

X. Jiang et al.

BRITISH JOURNAL OF CANCER (2012)

添加到收藏夹

Article Oncology

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

M. J. Proctor et al.

BRITISH JOURNAL OF CANCER (2011)

添加到收藏夹

Article Health Care Sciences & Services

Adjusting for multiple testing - when and how?

R Bender et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.